Trends in emergency coronary artery bypass grafting after percutaneous coronary intervention, 1994-2003.

[1]  E. Peterson,et al.  Validity of the Society of Thoracic Surgeons National Adult Cardiac Surgery Database. , 2004, The Annals of thoracic surgery.

[2]  V. L. Clark,et al.  Frequency and prognosis of emergency coronary artery bypass grafting after percutaneous coronary intervention for acute myocardial infarction. , 2003, The American journal of cardiology.

[3]  A. Rubboli,et al.  Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis. , 2003, Italian heart journal : official journal of the Italian Federation of Cardiology.

[4]  W. Byerly,et al.  Effects of preoperative enoxaparin versus unfractionated heparin on bleeding indices in patients undergoing coronary artery bypass grafting. , 2003, The Annals of thoracic surgery.

[5]  V. Poyen,et al.  Indications of coronary angioplasty and stenting in 2003: what is left to surgery? , 2003, The Journal of cardiovascular surgery.

[6]  E. de Marchena,et al.  Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary care center. , 2003, The Annals of thoracic surgery.

[7]  B. Horne,et al.  Preoperative Use of Enoxaparin Compared With Unfractionated Heparin Increases the Incidence of Re-Exploration for Postoperative Bleeding After Open-Heart Surgery in Patients Who Present With an Acute Coronary Syndrome: Clinical Investigation and Reports , 2002, Circulation.

[8]  William S Weintraub,et al.  A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). , 2002, Journal of the American College of Cardiology.

[9]  William S Weintraub,et al.  Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. , 2002, Journal of the American College of Cardiology.

[10]  R. Wunderink,et al.  Effect of clopidogrel on bleeding after coronary artery bypass surgery , 2001, Critical care medicine.

[11]  G. Breithardt,et al.  Emergency coronary artery bypass grafting after failed coronary angioplasty: what has changed in a decade? , 2000, The Annals of thoracic surgery.

[12]  R. Califf,et al.  Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing. , 2000, The Annals of thoracic surgery.

[13]  S. Clark,et al.  Effect of low molecular weight heparin (fragmin) on bleeding after cardiac surgery. , 2000, The Annals of thoracic surgery.

[14]  B. Jarvis,et al.  Clopidogrel , 2000, Drugs.

[15]  C. Dyke.  Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective. , 1999, American heart journal.

[16]  C. Dyke,et al.  Inhibitors of the platelet receptor glycoprotein IIb-IIIa and complications during percutaneous coronary revascularization. Management strategies for the cardiac surgeon. , 1999, The Journal of cardiovascular surgery.

[17]  H. White,et al.  New antiplatelet agents. , 1998, Australian and New Zealand journal of medicine.

[18]  E. Hannan,et al.  Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection. , 1998, Journal of the American College of Cardiology.

[19]  F. Grover,et al.  Impact of gender on coronary bypass operative mortality. , 1998, The Annals of thoracic surgery.

[20]  A L Shroyer,et al.  Updates to the Data Quality Review Program: the Society of Thoracic Surgeons Adult Cardiac National Database. , 1998, The Annals of thoracic surgery.

[21]  A L Shroyer,et al.  The 1996 coronary artery bypass risk model: the Society of Thoracic Surgeons Adult Cardiac National Database. , 1998, The Annals of thoracic surgery.

[22]  A. Jacobs,et al.  Factors influencing mortality after emergency coronary artery bypass grafting for failed percutaneous transluminal coronary angioplasty. , 1997, The Annals of thoracic surgery.

[23]  B. Leavitt,et al.  Use of the internal mammary artery graft in Northern New England. Northern New England Cardiovascular Disease Study Group. , 1997, Circulation.

[24]  T. Investigators.  Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. , 1997, Circulation.

[25]  H. Weisman,et al.  New Antiplatelet Agents: Platelet GPIIb/llla Antagonists , 1995, Thrombosis and Haemostasis.

[26]  F. Loop,et al.  Have PTCA failures requiring emergent bypass operation changed? , 1995, The Annals of thoracic surgery.

[27]  S. Davies,et al.  Emergency surgical revascularisation for coronary angioplasty complications. , 1994, British heart journal.

[28]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[29]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[30]  L. Noyez,et al.  Use of internal mammary artery for emergency grafting after failed coronary angioplasty. , 1994, The Annals of thoracic surgery.

[31]  L. Hillis,et al.  Percutaneous transluminal coronary angioplasty. , 1994, The American journal of the medical sciences.

[32]  D. Malenka,et al.  Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. , 1993, Circulation.

[33]  J. Piehler,et al.  Risk analysis of operative intervention for failed coronary angioplasty. , 1992, The Annals of thoracic surgery.

[34]  P. Douglas,et al.  Reperfusion and revascularization strategies for coronary artery disease in women. , 1992, JAMA.

[35]  B. Meier,et al.  Surgical standby for coronary balloon angioplasty. , 1992, JAMA.

[36]  D. Pennington,et al.  Emergency coronary artery bypass grafting for failed angioplasty: risk factors and outcome. , 1989, The Annals of thoracic surgery.

[37]  E. Jones,et al.  Percutaneous transluminal coronary angioplasty: role of the surgeon. , 1982, The Annals of thoracic surgery.

[38]  R. E. Clark,et al.  Impact of internal mammary artery conduits on operative mortality in coronary revascularization. , 1994, The Annals of thoracic surgery.